Features & Compatibility
KPV is a short tripeptide composed of Lysine, Proline and Valine. It represents the C-terminal amino-acid sequence of alpha-melanocyte-stimulating hormone (α-MSH) and is studied primarily for its interaction with inflammatory-response and cellular-signaling pathways.
Its compact structure makes KPV a useful research compound for investigating epithelial-cell responses, peptide transport, immune signaling and inflammation-related biological mechanisms in controlled laboratory environments. Research reference
Variants:
5mg10vials | 10mg10vials
For laboratory research use only. Not intended for human consumption or therapeutic use.
Customer Reviews
Related Products
BPC+TB500
This research blend combines BPC-157 and TB-500, two peptides investigated in laboratory models involving cellular repair and tissue-response mechanisms. BPC-157
CJC1295+Ipamorelin
This research blend combines CJC-1295, a synthetic analogue of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue
Klow80
Klow is a four-component research peptide blend combining GHK-Cu, TB-500, BPC-157 and KPV. The formula is designed for laboratory research
Retatrutide
Retatrutide, also known as LY3437943, is an investigational peptide designed to act on three metabolic hormone receptors: GIP, GLP-1, and
Semaglutide
Semaglutide is a GLP-1 analogue and GLP-1 receptor agonist that selectively binds to and activates GLP-1 receptors. It is widely
Tirzepatide
Tirzepatide is a modified peptide that acts as a dual agonist of the GIP and GLP-1 receptors. Its dual-receptor profile

Reviews
There are no reviews yet.